Astrazeneca Plc Quick Ratio (AZN) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Astrazeneca Plc  (NASDAQ: AZN)

Astrazeneca Plc's Quick Ratio

AZN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Astrazeneca Plc's Cash & cash equivalent, this led to improvement in Astrazeneca Plc's Quick Ratio to 0.13, Quick Ratio remained below Astrazeneca Plc average.

Within Major Pharmaceutical Preparations industry 509 other companies have achieved higher Quick Ratio than Astrazeneca Plc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 0 to 4497.

Explain Quick Ratio?
How much Cash & cash equivalents AZN´s has?
What are AZN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AZN/financial-strength
https://api.csimarket.com/api/v1/companies/AZN/fundamentals
https://api.csimarket.com/api/v1/companies/AZN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
AZN Quick Ratio (Dec 31 2025)
Q4		 0
Q3 		0
Q2 		0
Q1 		(Dec 31 2024)
Q4
Y / Y Current Liabilities Change 1.12 %
Y / Y Cash & cash equivalent Change -6.51 %
Quick Ratio MRQ 0.13
AZN's Total Ranking # 4497
Seq. Current Liabilities Change -
Seq. Cash & cash equivalent Change 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 510
Healthcare Sector # 997
Overall Market # 4497


Quick Ratio Statistics
High Average Low
0.31 0.17 0.1
0   (Jun 30 2018)




Financial Statements
Astrazeneca Plc's Current Liabilities $ 52,465 Millions Visit AZN's Balance sheet
Astrazeneca Plc's Cash & cash equivalent $ 6,869 Millions Visit AZN's Balance sheet
Source of AZN's Sales Visit AZN's Sales by Geography


Cumulative Astrazeneca Plc's Quick Ratio

AZN's Quick Ratio for the trailling 12 Months

AZN Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months 		0
12 Months 		0
12 Months 		(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -33.05 %
Y / Y Cash & cash equivalent TTM Growth -6.11 %
Quick Ratio TTM 0.92
Total Ranking TTM # 4369
Seq. Current Liabilities TTM Growth 1.89 %
Seq. Cash & cash equivalent TTM Growth -1.64 %

Quick ratio ranking by company, industry and sector >> Back to AZN Financial Strength Comparisons >> Go to Compare AZN Quick Ratio to its Competitors

On the trailing twelve months basis Due to drop in Current Liabilities in the Q4 2025 to $52,465.00 millions, cumulative Quick Ratio decreased to 0.92 above the AZN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 520 other companies have achieved higher Quick Ratio than Astrazeneca Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 0 to 4369.

Explain Quick Ratio?
How much Cash & cash equivalents AZN´s has?
What are AZN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 521
Healthcare Sector # 1053
Within the Market # 4369


trailing twelve months Quick Ratio Statistics
High Average Low
0.39 0.26 0.19
(Dec 31 2020)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Tiziana Life Sciences Ltd  0.36 $ 4.010  Millions$ 11.209  Millions
Amneal Pharmaceuticals Inc   0.35 $ 310.871  Millions$ 881.633  Millions
Lftd Partners Inc   0.35 $ 1.817  Millions$ 5.162  Millions
Ac Immune Sa  0.35 $ 33.764  Millions$ 97.299  Millions
Apnimed, Inc.  0.35 $ 41.890  Millions$ 120.962  Millions
Genmab A  0.34 $ 1,715.000  Millions$ 5,001.000  Millions
Aditxt Inc   0.34 $ 3.358  Millions$ 9.902  Millions
Medicure Inc   0.33 $ 2.938  Millions$ 8.896  Millions
Protagenic Therapeutics Inc new  0.32 $ 2.213  Millions$ 6.824  Millions
Sanofi  0.29 $ 9,515.549  Millions$ 32,510.093  Millions
Nrx Pharmaceuticals Inc   0.27 $ 7.797  Millions$ 28.578  Millions
Telix Pharmaceuticals Ltd  0.27 $ 147.909  Millions$ 542.825  Millions
Biolinerx Ltd   0.27 $ 3.250  Millions$ 12.123  Millions
Summit Therapeutics Inc   0.27 $ 16.538  Millions$ 61.966  Millions
Phibro Animal Health Corporation  0.26 $ 74.508  Millions$ 282.370  Millions
Cumberland Pharmaceuticals Inc   0.26 $ 11.445  Millions$ 44.519  Millions
Teva Pharmaceutical Industries Limited  0.25 $ 3,556.000  Millions$ 14,068.000  Millions
Organon and Co   0.24 $ 574.000  Millions$ 2,390.000  Millions
Novo Nordisk A  0.24 $ 4,920.176  Millions$ 20,636.707  Millions
Hcw Biologics Inc   0.23 $ 1.953  Millions$ 8.625  Millions
Galapagos Nv  0.23 $ 40.000  Millions$ 177.333  Millions
International Stem Cell Corporation  0.22 $ 0.993  Millions$ 4.579  Millions
Intercure Ltd   0.22 $ 46.466  Millions$ 214.365  Millions
Earth Science Tech Inc   0.21 $ 0.473  Millions$ 2.260  Millions
Redhill Biopharma Ltd   0.21 $ 3.971  Millions$ 19.221  Millions
Polomar Health Services, Inc.  0.21 $ 0.141  Millions$ 0.687  Millions
Citius Pharmaceuticals Inc   0.20 $ 7.721  Millions$ 38.207  Millions
Quantum Cyber N v   0.20 $ 0.832  Millions$ 4.240  Millions
Adlai Nortye Ltd  0.19 $ 8.056  Millions$ 41.628  Millions
Viatris Inc   0.19 $ 1,388.100  Millions$ 7,420.600  Millions

Date modified: 2026-07-07T09:23:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.